Blinatumomab for Acute Lymphoblastic Leukaemia (ALL)

This leaflet is not available in print. Download it as a PDF or visit our website to view all our ALL information to download.

This leaflet is about blinatumumab, an antibody therapy used to treat some people with Philadelphia chromosome-negative ALL, after they have had other treatment We cover what it is, who might have it and how you have it. We also cover its main side effects and any special precautions you need to take while you’re on it.